{"id":5910,"date":"2022-08-12T15:20:46","date_gmt":"2022-08-12T19:20:46","guid":{"rendered":"https:\/\/clariowebstg.wpengine.com\/?page_id=5910"},"modified":"2024-09-09T08:06:20","modified_gmt":"2024-09-09T12:06:20","slug":"your-pro-strategy-can-differentiate-your-oncology-drug","status":"publish","type":"page","link":"https:\/\/clario.com\/your-pro-strategy-can-differentiate-your-oncology-drug\/","title":{"rendered":"Differentiate your oncology drug with PROs"},"content":{"rendered":"<div class=\"clario-section\">\n  <div class=\"container\">\n      \n<div class=\"row align-items-center\">\n\t\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"891\" height=\"772\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/08\/drug-diff-fact-sheet-mockup.png\" alt=\"\" class=\"wp-image-6008\" srcset=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/08\/drug-diff-fact-sheet-mockup.png 891w, https:\/\/clario.com\/wp-content\/uploads\/2022\/08\/drug-diff-fact-sheet-mockup-600x520.png 600w, https:\/\/clario.com\/wp-content\/uploads\/2022\/08\/drug-diff-fact-sheet-mockup-768x665.png 768w\" sizes=\"auto, (max-width: 891px) 100vw, 891px\" \/><\/figure>\n\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n\n<h2 class=\"wp-block-heading\" id=\"h-how-your-pro-strategy-can-differentiate-your-drug\">How your PRO strategy can differentiate your drug<\/h2>\n\n\n\n<p>Sponsors can help differentiate their drugs by using:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>A range of PRO assessments:<\/strong> Understand the full scale of patient symptoms by using PROs that measure areas like physical and role function, symptomatic adverse events, and tumor-related symptoms.&nbsp;<\/li>\n\n\n\n<li><strong>Early-stage PROs (in phases I &amp; II):<\/strong> Understand the full range of potential symptoms early so you can use the data to optimize your Phase III PRO strategy\u2014ensuring that the most suitable symptomatic information is collected.<\/li>\n\n\n\n<li><strong>Technologies which collect objective data:<\/strong> Incorporate wearable and precision motion technologies that provide even richer information on how patients feel and function. Techniques may include continuous data actigraphy to measure fatigue or in-clinic postural sway measurements.<\/li>\n<\/ul>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/08\/Clario-eCOA-Oncology-Drug-Fact-Sheet-d2.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Download guide<\/a><\/div>\n<\/div>\n\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section light-grey-50\">\n  <div class=\"container\">\n      \n<div class=\"row\">\n\t\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n<div class=\"clario-feature-block row\" id=anchor ><div class=\"col-4 clario-feature-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"600\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/01\/Regulatory-Approval-Icon.svg\" class=\"img-fluid\" alt=\"Regulatory Approval Icon\" \/><\/div><div class=\"col-8 clario-feature-block-text \"><h3>Ensure your PRO strategy meets regulatory guidance<\/h3>\n<p>Regulators expect sponsors to place a stronger emphasis on understanding a drug&#8217;s full impact on patients&#8217; functioning, wellbeing and quality of life.<\/p><a href=\"https:\/\/clario.com\/its-not-just-about-survival-but-how-patients-are-living-with-cancer\/\" class=\"button secondary \">Learn more<\/a><\/div><\/div>\n\t<\/div>\n\n\n\n<div class=\"col-12 col-md-6\">\n\t\t\t\n<div class=\"clario-feature-block row\" id=anchor ><div class=\"col-4 clario-feature-block-image\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"600\" src=\"https:\/\/clario.com\/wp-content\/uploads\/2022\/01\/Patient-Recruitment-Icon.svg\" class=\"img-fluid\" alt=\"Patient Recruitment Icon\" \/><\/div><div class=\"col-8 clario-feature-block-text \"><h3>How to design a patient-centric cancer trial<\/h3>\n<p class=\"p2\">Make PRO collection simple, convenient and relevant to your patients.<\/p><a href=\"https:\/\/clario.com\/is-your-oncology-trial-truly-patient-focused\/\" class=\"button secondary \">Learn more<\/a><\/div><\/div>\n\t<\/div>\n\n<\/div>\n\n  <\/div>\n<\/div>\n\n\n<div class=\"clario-section purple\">\n  <div class=\"container\">\n      \n<div class=\"row mb-2 justify-content-center\">\n\t\n\n<div class=\"col-12 col-md-9\">\n\t\t\t\n\n<h2 class=\"wp-block-heading has-text-align-center\" id=\"evidence\">Clario&#8217;s oncology experience<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n<div class=\"clario-statistics-display row justify-content-center\"><div class=\"col-6 col-md-4 col-lg-3 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"\" src=\"\" height=\"auto\" width=\"auto\"><p class=\"stat\">3k<\/p><p class=\"stat-text\">Oncology trials<\/p><\/div><div class=\"col-6 col-md-4 col-lg-3 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"\" src=\"\" height=\"auto\" width=\"auto\"><p class=\"stat\">110k<\/p><p class=\"stat-text\">Sites<\/p><\/div><div class=\"col-6 col-md-4 col-lg-3 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"\" src=\"\" height=\"auto\" width=\"auto\"><p class=\"stat\">500k<\/p><p class=\"stat-text\">Patients<\/p><\/div><div class=\"col-6 col-md-4 col-lg-3 stat-block\"><img decoding=\"async\" class=\"stat-block-icons\" alt=\"\" src=\"\" height=\"auto\" width=\"auto\"><p class=\"stat\">85<\/p><p class=\"stat-text\">Drug approvals<\/p><\/div><\/div>\n\n\n<div class=\"wp-block-buttons mt-4 is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-16018d1d wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-secondary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clario.com\/solutions\/ecoa\/\">Explore eCOA solutions<\/a><\/div>\n<\/div>\n\n  <\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p> [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/clario.com\/your-pro-strategy-can-differentiate-your-oncology-drug\/\">Read More&#8230;<span class=\"screen-reader-text\"> from Differentiate your oncology drug with PROs<\/span><\/a><\/p>\n","protected":false},"author":7,"featured_media":2633,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-5910","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/pages\/5910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/comments?post=5910"}],"version-history":[{"count":0,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/pages\/5910\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/media\/2633"}],"wp:attachment":[{"href":"https:\/\/clario.com\/wp-json\/wp\/v2\/media?parent=5910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}